Key Insights

Highlights

Treatment Research

2 treatments under study, led by Rocuronium Iv Bolus 01 Mgkg Guided By Tof 04 And Ptc 2

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03910998Phase 4UnknownPrimary

Impact of Intraoperative Deep Neuromuscular Blockade on NOL-guided Opioid Requirement in LSC Colorectal Surgeries

Showing all 1 trials

Research Network

Common Treatments

  • Rocuronium Iv Bolus 01 Mgkg Guided By Tof 04 And Ptc 21
  • Rocuronium Iv Bolus 01 Mgkg Guided By Tof That Must Remain Between 13 During Surgery1

Active Sponsors

  • Ciusss de L'Est de l'Île de Montréal1
  • Merck Canada Inc.1

Top Investigators

Activity Timeline